Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

The safety, tolerance, and pharmacokinetics of amphotericin B lipid complex (ABLC) were studied in a cohort of pediatric cancer patients. Six children with hepatosplenic candidiasis (HSC) received 2.5 mg of ABLC/kg of body weight/day for 6 weeks for a total dosage of 105 mg/kg. Mean serum creatinine...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Walsh, T J, Whitcomb, P, Piscitelli, S, Figg, W D, Hill, S, Chanock, S J, Jarosinski, P, Gupta, R, Pizzo, P A
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1997
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164041/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9303390/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.9.1944
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!